We are live on
!
Find out more
HP
Harbourvest Partners Portfolio holdings
AUM
$101M
1-Year Est. Return
38.13%
This Fund
S&P 500
This Quarter
Est. Return
+27.12%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$746M
AUM Growth
+$490M
(+191%)
Cap. Flow
+$474M
Cap. Flow
% of AUM
63.58%
Top 10 Holdings %
Top 10 Hldgs %
89.94%
Holding
50
New
24
Increased
–
Reduced
2
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wayfair
W
|
+$313M |
| 2 |
Snowflake
SNOW
|
+$84.9M |
| 3 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
+$15.3M |
| 4 |
Roblox
RBLX
|
+$15.2M |
| 5 |
Relay Therapeutics
RLAY
|
+$12.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$10.2M |
| 2 |
WORK
Slack Technologies, Inc.
WORK
|
+$2.58M |
| 3 |
ADVM
Adverum Biotechnologies
ADVM
|
+$1.45M |
| 4 |
Progyny
PGNY
|
+$1.26M |
| 5 |
Seres Therapeutics
MCRB
|
+$795K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 45.86% |
| 2 | Technology | 30.45% |
| 3 | Healthcare | 19.21% |
| 4 | Communication Services | 2.99% |
| 5 | Financials | 1.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Wayfair
W
$12.5B
| $334M | 44.84% |
+1,062,126
| New | +$313M |
|
|
SWI
2
DELISTED
SolarWinds Corporation Common Stock
SWI
| $130M | 17.4% |
7,052,362
| – | – |
|
|
3
Snowflake
SNOW
$93.7B
| $73M | 9.79% |
+318,233
| New | +$84.9M |
|
|
EVLO
4
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $32.8M | 4.4% |
153,175
| – | – |
|
|
RUBY
5
DELISTED
Rubius Therapeutics, Inc
RUBY
| $26.2M | 3.51% |
986,878
| – | – |
|
|
SGTX
6
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| $16.6M | 2.22% |
56,980
| – | – |
|
|
NARI
7
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $15.8M | 2.12% |
+147,475
| New | +$15.3M |
|
|
KLDO
8
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $14.9M | 1.99% |
1,833,832
| – | – |
|
|
9
Roblox
RBLX
$35.4B
| $14.1M | 1.89% |
+217,569
| New | +$15.2M |
|
|
AXLA
10
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $13.4M | 1.79% |
112,319
| – | – |
|
|
11
Relay Therapeutics
RLAY
$3.99B
| $10.2M | 1.37% |
+296,402
| New | +$12.9M |
|
|
HAPN
12
Happen Inc
HAPN
$2.19B
| $8.48M | 1.14% |
513,440
| – | – |
|
13
ImmunityBio
IBRX
$7.3B
| $8.24M | 1.1% |
+347,009
| New | +$9M |
|
|
EB
14
DELISTED
Eventbrite
EB
| $8.21M | 1.1% |
+370,564
| New | +$7.46M |
|
15
Datadog
DDOG
$89.3B
| $7.76M | 1.04% |
+93,162
| New | +$8.98M |
|
16
Twilio
TWLO
$29.5B
| $4.97M | 0.67% |
+14,572
| New | +$5.46M |
|
17
DoorDash
DASH
$85.2B
| $3.92M | 0.53% |
+29,903
| New | +$5.01M |
|
|
LOV
18
DELISTED
Spark Networks SE American Depositary Shares
LOV
| $3.73M | 0.5% |
501,026
-1,550
| -0.3% | -$9.32K |
|
19
CrowdStrike
CRWD
$185B
| $2.5M | 0.33% |
+54,704
| New | +$2.89M |
|
|
ZUO
20
DELISTED
Zuora, Inc.
ZUO
| $2.43M | 0.33% |
163,894
| – | – |
|
21
Unity
U
$13.9B
| $2.2M | 0.29% |
+21,899
| New | +$2.7M |
|
22
Affirm
AFRM
$24.2B
| $1.98M | 0.27% |
+28,053
| New | +$2.73M |
|
23
Yext
YEXT
$564M
| $1.67M | 0.22% |
115,147
| – | – |
|
|
24
Seres Therapeutics
MCRB
$46.5M
| $1.02M | 0.14% |
2,468
-1,727
| -41% | -$795K |
|
25
Pacific Biosciences
PACB
$432M
| $782K | 0.1% |
+23,484
| New | +$822K |
|
Similar funds
VCM
TCI
RPC
XC
AWA
HWM
CG
ROP
Harbourvest Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Harbourvest Partners held 50 positions worth $746M, up 191% from $256M the previous quarter. Its ten largest holdings account for 90% of the portfolio.
Harbourvest Partners deployed $474M of net new capital in Q1 2021, opening 24 new positions. Its largest new stake was Wayfair: 1,062,126 shares worth $334M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 46% of assets, up from 1% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Seres Therapeutics, an estimated $795K trimmed.
- Harbourvest Partners's largest Q1 2021 buy was Wayfair: 1,062,126 shares worth $334M.
- Harbourvest Partners's biggest Q1 2021 reduction was Seres Therapeutics, cutting an estimated $795K.
- Harbourvest Partners fully exited Teladoc Health in Q1 2021, selling an estimated $10.2M.
- Harbourvest Partners's ten largest holdings make up 90% of its $746M portfolio in Q1 2021.
- Harbourvest Partners opened 24 new positions and closed 6 in Q1 2021.
- Harbourvest Partners's portfolio value rose 191% quarter-over-quarter to $746M.
Based on Harbourvest Partners's 13F filing for Q1 2021, filed 17 May 2021.